Anti-Human IL23A Recombinant Antibody(Brazikumab)
-
产品编号
YR1440
-
别名
科研级 Brazikumab ( 布雷库单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Brazikumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Brazikumab ( 布雷库单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Brazikumab |
Catalog Number | YR1440 |
Molecular Name | Brazikumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG2 Lambda |
Formulation | PBS, pH7.5 |
Background | Brazikumab (INN, development code MEDI2070) is a human monoclonal antibody designed for the treatment of Crohn's disease. This drug was developed by MedImmune. |
CAS Number | 1610353-18-8 |
Application | ELISA, IHC, FCM, IP, IF, Inhib, PK |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IL23A[Homo sapiens] |